Divergent Resistance Mechanisms to Immunotherapy Explain Responses in Different Skin Cancers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Divergent Resistance Mechanisms to Immunotherapy Explain Responses in Different Skin Cancers
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 2946
Publisher
MDPI AG
Online
2020-10-16
DOI
10.3390/cancers12102946
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
- (2020) Sharmilla Devi Jayasingam et al. Frontiers in Oncology
- Single-cell analysis reveals fibroblast heterogeneity and myeloid-derived adipocyte progenitors in murine skin wounds
- (2019) Christian F. Guerrero-Juarez et al. Nature Communications
- Cell lineage and communication network inference via optimization for single-cell transcriptomics
- (2019) Shuxiong Wang et al. NUCLEIC ACIDS RESEARCH
- Mathematical modeling of tumor-immune cell interactions
- (2019) Grace E. Mahlbacher et al. JOURNAL OF THEORETICAL BIOLOGY
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors
- (2019) William Damsky et al. Journal for ImmunoTherapy of Cancer
- Combined blockade of IL-6 and PD-1/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment
- (2018) Hirotake Tsukamoto et al. CANCER RESEARCH
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Single-cell RNA sequencing for the study of development, physiology and disease
- (2018) S. Steven Potter Nature Reviews Nephrology
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation
- (2018) Bo Peng et al. Cell Death & Disease
- 1280PTreatment patterns of melanoma by BRAF mutation status in the US in 2011-2017: A retrospective cohort study
- (2018) L Raskin et al. ANNALS OF ONCOLOGY
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma
- (2018) Satu Salmi et al. MELANOMA RESEARCH
- The Gene Ontology Resource: 20 years and still GOing strong
- (2018) NUCLEIC ACIDS RESEARCH
- Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature
- (2018) Francesco Sabbatino et al. Journal for ImmunoTherapy of Cancer
- Introduction to checkpoint inhibitors and cancer immunotherapy
- (2017) Arlene H. Sharpe IMMUNOLOGICAL REVIEWS
- New insights into the role of EMT in tumor immune escape
- (2017) Stéphane Terry et al. Molecular Oncology
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
- (2017) Evan J. Lipson et al. Journal for ImmunoTherapy of Cancer
- Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment
- (2016) Petra Kucerova et al. ANTI-CANCER DRUGS
- Anti-programmed cell death-1 therapy in nonmelanoma skin cancer
- (2016) J.K. Winkler et al. BRITISH JOURNAL OF DERMATOLOGY
- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- Construction of the landscape for multi-stable systems: Potential landscape, quasi-potential, A-type integral and beyond
- (2016) Peijie Zhou et al. JOURNAL OF CHEMICAL PHYSICS
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- The "cancer immunogram"
- (2016) C. U. Blank et al. SCIENCE
- Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
- (2016) Gerald S. Falchook et al. Journal for ImmunoTherapy of Cancer
- Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
- (2016) Sadakatsu Ikeda et al. npj Genomic Medicine
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- circlize implements and enhances circular visualization in R
- (2014) Zuguang Gu et al. BIOINFORMATICS
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
- (2014) Cole Trapnell et al. NATURE BIOTECHNOLOGY
- Quantifying Cell Fate Decisions for Differentiation and Reprogramming of a Human Stem Cell Network: Landscape and Biological Paths
- (2013) Chunhe Li et al. PLoS Computational Biology
- Quantifying the Waddington landscape and biological paths for development and differentiation
- (2011) J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- mRNA-Seq whole-transcriptome analysis of a single cell
- (2009) Fuchou Tang et al. NATURE METHODS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now